MMI SpA launches breakthrough technology, advancing robotic microsurgery with the world’s smallest wristed surgical instruments.

MMI SpA,(Medical Microinstruments S.P.A.) an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced the CE Mark, launch and first human use of its Symani Surgical System in Europe for open microsurgical procedures. The first four robotic surgeries were successfully performed in Florence, Italy, including three complex, post-traumatic lower limb reconstructions as well as a post-oncological reconstruction of the pharynx. Symani is the only system that offers wristed microinstruments designed to improve a surgeon’s ability to access and suture small, delicate anatomy. The platform provides motion scaling and tremor reduction to allow the surgeon to perform precise micro-movements. The proprietary, NanoWrist microinstruments add the needed dexterity to confidently access and suture hard to reach anatomy.In addition, the Symani Robotic System has the potential to expand human capabilities beyond what’s achievable today. This enables more surgeons to successfully perform microsurgery while expanding the capabilities of the surgeon to address the complexities of supermicrosurgery. The Symani Surgical System combines the benefits of tremor reduction and motion scaling (7-20x) with the world’s smallest wristed instrumentation, offering seven degrees of freedom and dexterity beyond the reach of human hands. The system’s NanoWrist instruments are designed to overcome the challenges of free-flap reconstructions, replantations, congenital malformations, peripheral nerve repairs and lymphatic surgery, which together represent over one million procedures annually in the U.S. and Europe alone..